Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-03-26 | CytomX Therapeutics, Inc. | McCarthy Sean A.
(CEO) |
M | Common Stock | A | 109768 | $1.57 - $1.57 | $172,873 |
| 2024-03-19 | CytomX Therapeutics, Inc. | ROWLAND LLOYD A
(General Counsel) |
S | Common Stock | D | 5268 | $2.09 - $2.09 | $10,986 |
| 2024-03-19 | CytomX Therapeutics, Inc. | Landau Jeffrey B
(Chief Business Officer) |
S | Common Stock | D | 6562 | $2.09 - $2.09 | $13,685 |
| 2024-01-18 | CytomX Therapeutics, Inc. | McCarthy Sean A.
(CEO) |
A | Common Stock | A | 90000 | $0.00 - $0.00 | $0 |
| 2024-01-18 | CytomX Therapeutics, Inc. | ROWLAND LLOYD A
(General Counsel) |
A | Common Stock | A | 25000 | $0.00 - $0.00 | $0 |
| 2024-01-18 | CytomX Therapeutics, Inc. | Ogden Christopher
(SVP, Finance and Accounting) |
A | Common Stock | A | 40000 | $0.00 - $0.00 | $0 |
| 2024-01-18 | CytomX Therapeutics, Inc. | Landau Jeffrey B
(Chief Business Officer) |
A | Common Stock | A | 30000 | $0.00 - $0.00 | $0 |
| 2024-01-18 | CytomX Therapeutics, Inc. | BELVIN MARCIA
(SVP, Chief Scientific Officer) |
A | Common Stock | A | 26250 | $0.00 - $0.00 | $0 |
| 2024-01-18 | CytomX Therapeutics, Inc. | Chu Yu-Waye
(Chief Medical Officer) |
A | Common Stock | A | 26250 | $0.00 - $0.00 | $0 |
| 2023-12-17 | CytomX Therapeutics, Inc. | ROWLAND LLOYD A
(General Counsel) |
M | Common Stock | A | 11250 | $0.00 - $0.00 | $0 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |